PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 10153397

Implementing a smoking cessation program for your patients.

L L Garry·U Atabek
View original source ↗Export metadata ↓

Abstract

PAs can improve the health of their patients by promoting healthy life-styles. By integrating a smoking cessation program into a surgical practice, the authors were able to achieve a cessation rate of 64% at 6 months and 1 year. The method, which includes screening, education, motivation, and follow-up, is applicable to any type of practice.

Explore related subjects

Follow-Up StudiesForms and Records ControlHealth PromotionHumansMotivationNew JerseyPatient Education as TopicPhysician AssistantsProfessional-Patient RelationsProgram DevelopmentSmokingSmoking CessationSmoking PreventionJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

L L Garry, U Atabek. 1995. Implementing a smoking cessation program for your patients.. https://pubmed.ncbi.nlm.nih.gov/10153397/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2000

[Risk of early therapeutic failure after prostatectomy is relatively great. Tumor grade and preoperative serum level of PSA are significant prognostic variables].

Prostate cancer is the most common malignancy among males in the West. Any reduction in mortality would require early detection of cases in which curative treatment is possible. From 1994 through 1998, 105 patients with clinically localised T1-T2 tumours were operated via radical prostatectomy at Karolinska sjukhuset in Stockholm. Three patients were lost to follow-up. We obtained clinical data from patients' records and used pathologist reviews to characterise tumours regarding grade and histopathological stage. We used PSA in serum as a surrogate endpoint, with a value above 0.6 ng/ml designated as treatment failure. Outcome was examined with respect to tumour grade, histopathological stage and pre-operative PSA level. Altogether 22% of patients showed PSA failure during follow-up. No mortality due to prostate cancer was recorded. We found that both tumour grade and pre-operative serum PSA level correlated well with treatment failure (P < 0.01). Our findings illustrate the diagnostic difficulties involved, since a relatively large percentage of patients were registered for treatment failure shortly after radical prostatectomy.

Follow-Up Studies↗